TABLE 1 from Phase I Study of mTORC1/2 Inhibitor Sapanisertib (CB-228/TAK-228) in Combination with Metformin in Patients with mTOR/AKT/PI3K Pathway Alterations and Advanced Solid Malignancies

Name: TABLE 1 from Phase I Study of mTORC1/2 Inhibitor Sapanisertib (CB-228/TAK-228) in Combination with Metformin in Patients with mTOR/AKT/PI3K Pathway Alterations and Advanced Solid Malignancies
Creator: aacr.figshare.com
Published: 2024-02-12 00:00:00
License: 暂无描述

aacr.figshare.com2024-02-12 更新2025-03-23 收录

下载链接：

https://aacr.figshare.com/articles/dataset/TABLE_1_from_Phase_I_Study_of_mTORC1_2_Inhibitor_Sapanisertib_CB-228_TAK-228_in_Combination_with_Metformin_in_Patients_with_i_mTOR_AKT_PI3K_i_Pathway_Alterations_and_Advanced_Solid_Malignancies/25206409/1

下载链接

链接失效反馈

官方服务：

资源简介：

Baseline patient demographics

基线患者人口统计学信息

提供机构：

aacr.figshare.com